Tuesday, 02 January 2024 12:17 GMT

Certara To Report Third Quarter 2025 Financial Results On November 6Th, 2025


(MENAFN- GlobeNewsWire - Nasdaq) RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 after the market close on Thursday, November 6th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.

Investors interested in listening to the conference call are required to register online . It is recommended to register at least one day in advance.

A live and archived webcast of the event will be available on the“Investors” section of the Certara website at .

About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at certara.

Investor Relations Contact:
David Deuchler
Gilmartin Group
...

Media Contact:
Alyssa Horowitz
...


MENAFN10102025004107003653ID1110178020



Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.